Evercore ISI Group Maintains Outperform on BioNTech, Lowers Price Target to $130
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Evercore ISI Group analyst Cory Kasimov maintains BioNTech (NASDAQ:BNTX) with a Outperform and lowers the price target from $135 to $130.
Evercore ISI Group analyst Cory Kasimov maintains BioNTech (NASDAQ:BNTX) with a Outperform and lowers the price target from $135 to $130.